… levels of serum GFAP were detected within 1 h of injury, compared with levels in participants
… with TBI peaked at 20 h after injury, and finally declined slowly until 72 h after injury 35 . …

Since coronavirus disease-2019 (COVID-19) outbreak in January 2020, several pieces of
evidence suggested an association between the spectrum of Guillain–Barré syndrome (GBS) …

… 1 (T H 1) and T H 17 cytokines in astrocytes and immune cells in chronic active plaque
samples. Other potential biomarkers include intrathecally produced CSF autoantibodies that react …

Background The diagnostic and pathophysiological relevance of antibodies to aquaporin-4 (AQP4-Ab)
in patients with neuromyelitis optica spectrum disorders (NMOSD) has been …

… Tumani has received funding for travel from Bayer Schering Pharma, Novartis, Biogen
Idec, Merck Serono, and Teva Pharmaceutical Industries Ltd.; has received speaker and/or …

Background The cerebrospinal fluid (CSF) biomarkers amyloid β (Aβ)‐42, total‐tau (T‐tau),
and phosphorylated‐tau (P‐tau) demonstrate good diagnostic accuracy for Alzheimer's …

Creutzfeldt–Jakob disease (CJD) is a rare, fatal, neurodegenerative disease caused by a
transmissible agent designated as proteinaceous infectious agent (prion). Searching for …

Objective Neuromyelitis optica (NMO) attacks often are severe, are difficult to treat, and leave
residual deficits. Here, we analyzed the frequency, sequence, and efficacy of therapies …

Background and objective: We explored which clinical and biochemical variables predict
conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS…

We determined the cytokine messenger RNA (mRNA) expression pattern of blood mononuclear
cells in 29 patients with relapsing‐remitting multiple sclerosis every 4 weeks over a …